These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1033 related articles for article (PubMed ID: 27026798)

  • 1. Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(3):1-60. PubMed ID: 27026798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt J; Hutchinson J; Royle P; Bryant J
    Health Technol Assess; 2005 Nov; 9(45):1-132, iii-iv. PubMed ID: 16303098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic Evaluation of Left Ventricular Assist Devices for Patients With End Stage Heart Failure Who Are Ineligible for Cardiac Transplantation.
    Chew DS; Manns B; Miller RJH; Sharma N; Exner DV
    Can J Cardiol; 2017 Oct; 33(10):1283-1291. PubMed ID: 28941608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy.
    Rogers JG; Bostic RR; Tong KB; Adamson R; Russo M; Slaughter MS
    Circ Heart Fail; 2012 Jan; 5(1):10-6. PubMed ID: 22052901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation.
    Beese S; Avşar TS; Price M; Quinn D; Lim HS; Dretzke J; Ogwulu CO; Barton P; Jackson L; Moore D
    Health Technol Assess; 2024 Aug; 28(38):1-237. PubMed ID: 39189844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of continuous-flow left ventricular assist devices.
    Neyt M; Van den Bruel A; Smit Y; De Jonge N; Erasmus M; Van Dijk D; Vlayen J
    Int J Technol Assess Health Care; 2013 Jul; 29(3):254-60. PubMed ID: 23763844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure.
    Long EF; Swain GW; Mangi AA
    Circ Heart Fail; 2014 May; 7(3):470-8. PubMed ID: 24563450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation.
    Clegg AJ; Scott DA; Loveman E; Colquitt JL; Royle P; Bryant J
    Eur Heart J; 2006 Dec; 27(24):2929-38. PubMed ID: 16603577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program.
    Clarke A; Pulikottil-Jacob R; Connock M; Suri G; Kandala NB; Maheswaran H; Banner NR; Sutcliffe P
    Int J Cardiol; 2014 Feb; 171(3):338-45. PubMed ID: 24424339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-Effectiveness of Left Ventricular Assist Devices in Ambulatory Patients With Advanced Heart Failure.
    Baras Shreibati J; Goldhaber-Fiebert JD; Banerjee D; Owens DK; Hlatky MA
    JACC Heart Fail; 2017 Feb; 5(2):110-119. PubMed ID: 28017351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost-utility of left ventricular assist devices for end-stage heart failure patients ineligible for cardiac transplantation: a systematic review and critical appraisal of economic evaluations.
    Neyt M; Van den Bruel A; Smit Y; De Jonge N; Vlayen J
    Ann Cardiothorac Surg; 2014 Sep; 3(5):439-49. PubMed ID: 25452904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: A United Kingdom perspective.
    Lim HS; Shaw S; Carter AW; Jayawardana S; Mossialos E; Mehra MR
    J Heart Lung Transplant; 2022 Feb; 41(2):174-186. PubMed ID: 34922821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of the implantable HeartMate II left ventricular assist device for patients awaiting heart transplantation.
    Moreno SG; Novielli N; Cooper NJ
    J Heart Lung Transplant; 2012 May; 31(5):450-8. PubMed ID: 22115674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left Ventricular Assist Device as Destination Therapy: a State of the Science and Art of Long-Term Mechanical Circulatory Support.
    Hanff TC; Birati EY
    Curr Heart Fail Rep; 2019 Oct; 16(5):168-179. PubMed ID: 31631240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term continuous flow left ventricular assist device support and end-organ function: prospects for destination therapy.
    Slaughter MS
    J Card Surg; 2010 Jul; 25(4):490-4. PubMed ID: 20642766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support.
    Nunes AJ; MacArthur RG; Kim D; Singh G; Buchholz H; Chatterley P; Klarenbach SW
    Value Health; 2016 Jun; 19(4):494-504. PubMed ID: 27325342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.
    Nativi JN; Drakos SG; Kucheryavaya AY; Edwards LB; Selzman CH; Taylor DO; Hertz MI; Kfoury AG; Stehlik J
    J Heart Lung Transplant; 2011 Aug; 30(8):854-61. PubMed ID: 21571550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure.
    Pruijsten RV; Lok SI; Kirkels HH; Klöpping C; Lahpor JR; de Jonge N
    Eur J Heart Fail; 2012 Mar; 14(3):319-25. PubMed ID: 22294758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.